30 closest matches · ranked by relevance
Age Related Macular Degeneration · Retinitis Pigmentosa · Congenital Stationary Night Blindness
Primary: Visual Perception to Infrared: Mean Minimal Intensity (uW) at Which Participants Could See IR Between 900 - 1400 nm. — 0.671770454; 0.809204; 0.205456012; 0.222247 uW…
Mild Cognitive Impairment · Alzheimer Disease
Primary: Melatonin Levels — 0.89; 0.84; 0.9; 0.68 pg/mL
Vitiligo
Primary: Percent Repigmentation — 48.5; 2.5 Percent Repigmentation
Cataract
Primary: Photostress Recovery Time in Seconds. — 36; 41.46; 24.88 seconds
Atopic Dermatitis
Primary: Number of Pruritus Events in Last 30 Days — 7.4; 1.9 Events
Non-visual Photoreception
Primary: Melatonin Suppression — 71.4; 70.1; 54.3; 32.5 Percentage suppression — p=0.73
Pain
Primary: Change in Pain Level — 1.15; -0.04; 1.07 score on a scale
Skin Care
Primary: Percentage of Participants With Photo-initiated Potential Sensitization Reaction — 0; 0; 0; 0 Participants
Healthy
Primary: Photosensitivity Index at 24 Hours Under Condition 1 (i.e., Under Full Range of UVB/UVA Exposure, Simulating Midday Summer Outdoor Sun Exposure) — 0.93; 1.01; 1.00; 1.04…
Healthy
Primary: Frequency Distribution of Skin Irritation Scores — 39; 10; 3; 0 Scores on a scale
Psoriasis
Primary: Percent Lesion Clearance — 75.7; 8 Percent Clearance
PTSD
Primary: Change in PTSD Checklist for DSM-5 (PCL-5) Scores Over 4 Weeks of Treatment — 15.11; 2.50 units on a scale
Bipolar Disorder
Primary: Test the Effect of Transcranial Photobiomodulation (tPBM) on Cerebral Blood Flow (CBF) — 6611.645; 6666.398 A.U.
Alzheimer Disease
Primary: Change in Alzheimer's Disease Assessment Scale-cognitive Subscale (ADAS-cog) — 0.94; 1.4 Ratio — p=0.07
Healthy
Primary: Skin Reaction Score — 0.4; 0.5; 0.1; 0.4 units on a scale
Seasonal Affective Disorder
Primary: SIGH-ADS Score — 29.4; 25.8; 5.6; 4.5 units on a scale — p=0.74
Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma · Recurrent Mycosis Fungoides/Sezary Syndrome · Stage I Cutaneous T-cell Non-Hodgkin Lymphoma
Primary: MTD of Photodynamic Therapy — 150 J/cm^2
Grover's Disease · Psoriasis Vulgaris
Primary: Efficacy of Blue Light Therapy for Patients With Grover's Disease — 27; 6 lesion count
Vitiligo
Primary: Change in Pigmentation (Total and Individual Body Parts) Using the Vitiligo Area Scoring Index (VASI) — 0.00; 0.00; 0.00; 0.00 Change in VASI score from baseline
Cataract
Primary: Photostress Recovery Time — 5.66; 6.94 seconds
Actinic Keratosis
Primary: Changes From Baseline in Actinic Keratosis - Lesion Base Count. — 1.15; 2.65; 1.15; 2.60 lesions — p=<0.001
Basal Cell Nevus Syndrome
Primary: Tumor Clearance Rate Following Red or Blue Light PDT — 87.3; 99 Percentage of tumors cleared
Basal Cell Carcinoma
Primary: Number of Participants With Histologically Confirmed Complete Response — 25; 11 Participants
Visual Performance
Primary: Photopic Contrast Sensitivity at 6 Cpd — 1.46; 1.91 Log Unit
Actinic Keratosis
Primary: Percent Change in the Number of Actinic Keratoses — -75 % change in number of actinic keratoses
Actinic Keratoses
Primary: Change in Treatment Symptoms — 3.9; 0.5; 0.37 score on a scale
Acne Vulgaris
Primary: Photoactive Porphyrins Level — 33.0; 24.8; 19.7 Fluorescence intensity unit
Diabetic Macular Oedema
Primary: Change in Measurement in Central Macular Thickness Measured by Spectral Domain Optical Coherence Tomography( OCT) at One Month — -25.2; -29.9; -58.9 micrometers — p=0.04
Seasonal Affective Disorder
Primary: Structured Interview Guide for the Hamilton Depression Scale - Seasonal Affective Disorder Version (SIGH-SAD); Weekly for Three Weeks — 16.3; 8 units on a scale
Phototoxicity
Primary: Within-subject Comparison and Evaluator Rating of Possible Dermal Reactions (Erythema, Edema and Other Signs of Cutaneous Irritation), After Application of MC2-01 Cream…